Colgate Announces 2nd Quarter 2020 Results

NEW YORK--(BUSINESS WIRE)--July 31, 2020--Colgate-Palmolive Company (NYSE:CL)

• Net sales increased 1.0%, Organic sales* increased 5.5%
• GAAP EPS grew 9% to $0.74, Base Business EPS* grew 3% to $0.74
• GAAP Gross profit margin increased 110 basis points to 60.8%, Base Business Gross profit margin* increased 120 basis points to 60.8%
• Net cash provided by operations was $1,794 million
• Colgate’s leadership in toothpaste continued with its global market share at 40.0% year to date
• Colgate’s leadership in manual toothbrushes continued with its global market share at 31.0% year to date
• The Company is not providing 2020 financial guidance due to the continued uncertainty surrounding the business impacts from COVID-19 and related macroeconomic volatility

Second Quarter Total Company Results (GAAP)
($ in millions except per share amounts)	2020	2019	Change
Net Sales	$3,897	$3,866	+1.0%
EPS (diluted)	$0.74	$0.68	+9%
Second Quarter Total Company Results (Base Business - Non-GAAP)*
($ in millions except per share amounts)	2020	2019	Change
Organic Sales Growth			+5.5%
Base Business EPS (diluted)	$0.74	$0.72	+3%

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” and “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

Colgate-Palmolive Company (NYSE:CL) today reported results for second quarter 2020. Noel Wallace, Chairman, President and Chief Executive Officer, commented, “Our momentum continued in the second quarter, despite the many challenges brought on by the global COVID-19 pandemic, including government actions to stem the spread of the virus. Our strategy has accelerated our growth over the past two years, and we continue to execute that strategy with agility to position us to win both during the pandemic and during the recovery. The ability of our teams on the ground to quickly adapt to new ways of working in the face of these challenges has been extraordinary.

“While net sales growth was significantly impacted by foreign exchange, the 5.5% organic sales growth reflected a good balance of positive volume and higher pricing on a worldwide basis and was led by strong growth in North America and Hill’s.

“We continue to see elevated demand across our geographies in certain categories such as liquid hand soap, dish liquid, bar soap and cleaners. In other categories, we are starting to see the impact of consumers working down their pantry inventories, particularly in Europe.

"The gross margin expansion in the quarter allowed us to invest behind our brands. Over the second half of the year, we will continue to fund strong consumer programs to drive our business.

“Looking ahead, we continue to expect a mid-single digit negative impact on net sales for the year from foreign exchange, based on current spot rates. Given the continued uncertainty related to the impact of the virus and government actions to stem the virus, including macroeconomic impacts, we have decided not to reinstate our financial guidance for 2020 at this time. As we proceed through this pandemic we plan to reinstate our guidance when we have the visibility to forecast our results with more confidence.”

Divisional Performance

The following are comments about divisional performance for second quarter 2020 versus the year ago period. See attached "Table 6 - Geographic Sales Analysis Percentage Changes" and "Table 5 - Segment Information" for additional information on net sales and operating profit by division.

Second Quarter Sales Growth By Division (% change 2Q 2020 vs. 2Q 2019)
	Net Sales	Organic Sales*	As Reported Volume	Organic Volume	Pricing	FX
North America	+12.0%	+11.0%	+13.0%	+11.5%	-0.5%	-0.5%
Latin America	-13.5%	+4.5%	-4.5%	-4.5%	+9.0%	-18.0%
Europe	+5.0%	-1.5%	+7.5%	-1.5%	—%	-2.5%
Asia Pacific	-3.0%	+0.5%	-3.0%	-3.0%	+3.5%	-3.5%
Africa/Eurasia	-6.0%	+2.5%	+0.5%	-1.5%	+4.0%	-10.5%
Hill's	+9.5%	+11.5%	+7.5%	+7.5%	+4.0%	-2.0%
Total Company	+1.0%	+5.5%	+3.5%	+2.0%	+3.5%	-6.0%

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.   The impact of the previously disclosed acquisitions of the Filorga skin health business, the new joint venture in Nigeria and the Hello oral care business on as reported volume was 1.5% for Total Company and 9.0%, 2.0% and 1.5% for Europe, Africa/Eurasia and North America, respectively.

Second Quarter Operating Profit By Division ($ in millions)
	2Q 2020	% Change vs 2Q 2019	% to Net Sales	Change in basis points vs 2Q 2019 % to Net Sales
North America	$254	—%	26.8%	-320
Latin America	$229	-9%	28.4%	+140
Europe	$158	7%	25.6%	+40
Asia Pacific	$176	1%	28.2%	+130
Africa/Eurasia	$56	19%	24.5%	+520
Hill's	$191	14%	28.4%	+110
Total Company, As Reported	$946	7.0%	24.3%	+130
Total Company, Base Business*	$946	1.9%	24.3%	+30

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

North America (24% of Company Sales)

• Organic sales growth was driven by the United States and Canada.
• In the United States, Colgate's share of the toothpaste market is 34.9% year to date and its share of the manual toothbrush market is 40.9% year to date.
• The decrease in Operating profit as a percentage of Net sales was primarily due to increased advertising investment, unfavorable mix, higher overhead expenses, primarily driven by higher logistics costs, and higher raw and packaging material costs, partially offset by cost savings from the Company’s funding-the-growth initiatives.

Latin America (21% of Company Sales)

• Organic sales growth in Argentina, Brazil, the Caribbean region and Colombia was partially offset by an organic sales decline in Mexico.
• The increase in Operating profit as a percentage of Net sales was primarily due to cost savings from the Company’s funding-the-growth initiatives, higher pricing and lower overhead costs, partially offset by higher raw and packaging material costs, which included foreign exchange transaction costs.

Europe (16% of Company Sales)

• Organic sales declines in the United Kingdom, Germany and Spain were partially offset by organic sales growth in Switzerland and Belgium.
• The increase in Operating profit as a percentage of Net sales was primarily due to cost savings from the Company’s funding-the-growth initiatives, favorable mix and decreased advertising investment, partially offset by higher overhead expenses, higher raw and packaging material costs, which included foreign exchange transaction costs, and amortization expense related to the Filorga skin health acquisition.

Asia Pacific (16% of Company Sales)

• Organic sales growth in the Greater China region and Australia was partially offset by organic sales declines in Thailand and India.
• The increase in Operating profit as a percentage of Net sales was primarily due to higher pricing, cost savings from the Company's funding-the-growth initiatives and decreased advertising investment, partially offset by higher raw and packaging material costs, which included foreign exchange transaction costs, and higher overhead expenses.

Africa/Eurasia (6% of Company Sales)

• Organic sales growth was led by Turkey, the Saudi Arabia/Gulf States region and South Africa.
• The increase in Operating profit as a percentage of Net sales was primarily due to decreased advertising investment, cost savings from the Company’s funding-the-growth initiatives and higher pricing, partially offset by higher overhead expenses and higher raw and packaging material costs, which included foreign exchange transaction costs.

Hill's Pet Nutrition (17% of Company Sales)

• Organic sales growth was led by the United States and Europe.
• The increase in Operating profit as a percentage of Net sales was primarily due to lower overhead expenses, cost savings from the Company’s funding-the-growth initiatives and higher pricing, partially offset by increased advertising investment and higher raw and packaging material costs.

Webcast Information

At 8:30 a.m. ET today, Colgate will host a conference call regarding second quarter results. To access this call as a webcast, please go to Colgate’s website at www.colgatepalmolive.com.

About Colgate-Palmolive

Colgate-Palmolive is a leading global consumer products company with 34,000 people dedicated to improving the health and wellness of people and their pets. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition and reaching more than 200 countries and territories, Colgate teams are developing, producing, distributing and selling health and hygiene products and pet nutrition offerings essential to society through brands such as Colgate, Palmolive, elmex, meridol, Tom’s of Maine, hello, Sorriso, Speed Stick, Softsoap, Irish Spring, Protex, Sanex, Filorga, eltaMD, PCA Skin, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet. The Company also is recognized for its leadership and innovation in promoting environmental sustainability and community wellbeing, including its achievements in saving water, reducing waste, promoting recyclability and improving the oral health of children through its Bright Smiles, Bright Futures program, which has reached more than one billion children since 1991. For more information about Colgate’s global business and how the Company is building a future to smile about, visit www.colgatepalmolive.com. CL-E

Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).

Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In certain limited circumstances, the COVID-19 pandemic has impacted the ability of our third-party vendors to provide the Company with reliable updated market share data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

Cautionary Statement on Forward-Looking Statements

This press release and the related webcast may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (SEC) in its rules, regulations and releases) that set forth anticipated results based on management’s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin growth, earnings per share levels, financial goals, the impact of foreign exchange, the impact of COVID-19, cost-reduction plans, tax rates, new product introductions, commercial investment levels, acquisitions, divestitures, share repurchases, or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of these statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. For more information about factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, investors should refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 and subsequent Quarterly Reports on Form 10-Q). Copies of these filings may be obtained upon request from the Company’s Investor Relations Department or on the Company’s website at www.colgatepalmolive.com.

Non-GAAP Financial Measures

The following provides definitions and other information regarding the non-GAAP financial measures used in this press release and/or the related webcast, which may not be the same as or comparable to similar measures presented by other companies:

• Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, charges resulting from the Global Growth and Efficiency Program, acquisition-related costs and a benefit related to a recent reorganization of the ownership structure of certain foreign subsidiaries and a new operating structure being implemented within one of the Company's divisions.
• Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments.
• Free cash flow before dividends: Net cash provided by operations less Capital expenditures.

This press release discusses Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See “Geographic Sales Analysis Percentage Changes” for the three and six months ended June 30, 2020 versus 2019 included with this release for a comparison of Organic sales growth to Net sales growth in accordance with GAAP.

Worldwide Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to Colgate-Palmolive Company and Diluted earnings per common share are disclosed on both an as reported (GAAP) and Base Business (non-GAAP) basis. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, gains and losses from certain divestitures and certain unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. See “Non-GAAP Reconciliations” for the three and six months ended June 30, 2020 and 2019 included with this release for a reconciliation of these financial measures to the related GAAP measures.

The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company’s underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.

As management uses free cash flow before dividends to evaluate the Company’s ability to satisfy current and future obligations, repurchase stock, pay dividends and fund future business opportunities, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See “Condensed Consolidated Statements of Cash Flows” for the six months ended June 30, 2020 and 2019 for a comparison of free cash flow before dividends to Net cash provided by operations as reported in accordance with GAAP.

(See attached tables for second quarter results.)

Table 1
Colgate-Palmolive Company
Condensed Consolidated Statements of Income
For the Three Months Ended June 30, 2020 and 2019
(Dollars in Millions Except Per Share Amounts) (Unaudited)
		2020				2019
Net sales		$	3,897			$	3,866
Cost of sales			1,528				1,558
Gross profit			2,369				2,308
Gross profit margin			60.8	%			59.7	%
Selling, general and administrative expenses			1,395				1,369
Other (income) expense, net			28				51
Operating profit			946				888
Operating profit margin			24.3	%			23.0	%
Non-service related postretirement costs			20				27
Interest (income) expense, net			35				38
Income before income taxes			891				823
Provision for income taxes			216				205
Effective tax rate			24.2	%			24.9	%
Net income including noncontrolling interests			675				618
Less: Net income attributable to noncontrolling interests			40				32
Net income attributable to Colgate-Palmolive Company		$	635			$	586
Earnings per common share
Basic		$	0.74			$	0.68
Diluted		$	0.74			$	0.68
Supplemental Income Statement Information
Average common shares outstanding
Basic			857.4				859.4
Diluted			858.9				861.9
Advertising		$	439			$	416

Table 2
Colgate-Palmolive Company
Condensed Consolidated Statements of Income
For the Six Months Ended June 30, 2020 and 2019
(Dollars in Millions Except Per Share Amounts) (Unaudited)
		2020				2019
Net sales		$	7,994			$	7,750
Cost of sales			3,160				3,155
Gross profit			4,834				4,595
Gross profit margin			60.5	%			59.3	%
Selling, general and administrative expenses			2,868				2,734
Other (income) expense, net			68				94
Operating profit			1,898				1,767
Operating profit margin			23.7	%			22.8	%
Non-service related postretirement costs			41				52
Interest (income) expense, net			71				78
Income before income taxes			1,786				1,637
Provision for income taxes			363				419
Effective tax rate			20.3	%			25.6	%
Net income including noncontrolling interests			1,423				1,218
Less: Net income attributable to noncontrolling interests			73				72
Net income attributable to Colgate-Palmolive Company		$	1,350			$	1,146
Earnings per common share
Basic(1)		$	1.58			$	1.33
Diluted(1)		$	1.57			$	1.33
Supplemental Income Statement Information
Average common shares outstanding
Basic			857.1				860.7
Diluted			858.6				862.7
Advertising		$	923			$	845

Note:

(1) Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not equal the earnings per share for any year-to-date period.

Table 3
Colgate-Palmolive Company
Condensed Consolidated Balance Sheets
As of June 30, 2020, December 31, 2019 and June 30, 2019
(Dollars in Millions) (Unaudited)
		June 30,				December 31,				June 30,
		2020				2019				2019
Cash and cash equivalents		$	997			$	883			$	863
Receivables, net			1,231				1,440				1,590
Inventories			1,524				1,400				1,322
Other current assets			460				456				480
Property, plant and equipment, net			3,483				3,750				3,793
Goodwill			3,628				3,508				2,536
Other intangible assets, net			2,787				2,667				1,609
Other assets			1,031				930				958
Total assets		$	15,141			$	15,034			$	13,151
Total debt		$	7,392			$	7,847			$	6,645
Other current liabilities			4,072				3,524				3,777
Other non-current liabilities			2,945				3,105				2,739
Total liabilities			14,409				14,476				13,161
Total Colgate-Palmolive Company shareholders’ equity			268				117				(347	)
Noncontrolling interests			464				441				337
Total liabilities and equity		$	15,141			$	15,034			$	13,151
Supplemental Balance Sheet Information
Debt less cash, cash equivalents and marketable securities(1)		$	6,370			$	6,941			$	5,716
Working capital % of sales			(5.5	)%			(1.6	)%			(2.9	)%

Note:
(1) Marketable securities of $25, $23 and $66 as of June 30, 2020, December 31, 2019 and June 30, 2019, respectively, are included in Other current assets.

Table 4
Colgate-Palmolive Company
Condensed Consolidated Statements of Cash Flows
For the Six Months Ended June 30, 2020 and 2019
(Dollars in Millions) (Unaudited)
		2020				2019
Operating Activities
Net income including noncontrolling interests		$	1,423			$	1,218
Adjustments to reconcile Net income including noncontrolling interests to Net cash provided by operations:
Depreciation and amortization			266				256
Restructuring and termination benefits, net of cash			(35	)			21
Stock-based compensation expense			32				34
Deferred income taxes			(147	)			53
Voluntary benefit plan contributions			—				(102	)
Cash effects of changes in:
Receivables			121				(178	)
Inventories			(176	)			(63	)
Accounts payable and other accruals			347				(14	)
Other non-current assets and liabilities			(37	)			24
Net cash provided by operations			1,794				1,249
Investing Activities
Capital expenditures			(159	)			(146	)
Purchases of marketable securities and investments			(48	)			(80	)
Proceeds from sale of marketable securities and investments			42				14
Payment for acquisitions, net of cash acquired			(352	)			—
Net cash used in investing activities			(517	)			(212	)
Financing Activities
Principal payments on debt			(2,102	)			(3,105	)
Proceeds from issuance of debt			1,620				3,368
Dividends paid			(784	)			(770	)
Purchases of treasury shares			(228	)			(664	)
Proceeds from exercise of stock options			353				267
Net cash provided by (used in) financing activities			(1,141	)			(904	)
Effect of exchange rate changes on Cash and cash equivalents			(22	)			4
Net increase (decrease) in Cash and cash equivalents			114				137
Cash and cash equivalents at beginning of the period			883				726
Cash and cash equivalents at end of the period		$	997			$	863
Supplemental Cash Flow Information
Free cash flow before dividends (Net cash provided by operations less Capital expenditures)
Net cash provided by operations		$	1,794			$	1,249
Less: Capital expenditures			(159	)			(146	)
Free cash flow before dividends		$	1,635			$	1,103
Income taxes paid		$	349			$	463

Table 5
Colgate-Palmolive Company
Segment Information
For the Three and Six Months Ended June 30, 2020 and 2019
(Dollars in Millions) (Unaudited)
		Three Months Ended June 30,								Six Months Ended June 30,
		2020				2019				2020				2019
Net Sales
Oral, Personal and Home Care
North America		$	949			$	846			$	1,878			$	1,699
Latin America			805				929				1,694				1,818
Europe			617				588				1,292				1,190
Asia Pacific			625				646				1,258				1,346
Africa/Eurasia			229				244				481				484
Total Oral, Personal and Home Care			3,225				3,253				6,603				6,537
Pet Nutrition			672				613				1,391				1,213
Total Net Sales		$	3,897			$	3,866			$	7,994			$	7,750
		Three Months Ended June 30,								Six Months Ended June 30,
		2020				2019				2020				2019
Operating Profit
Oral, Personal and Home Care
North America		$	254			$	254			$	512			$	503
Latin America			229				251				478				483
Europe			158				148				312				299
Asia Pacific			176				174				337				363
Africa/Eurasia			56				47				112				93
Total Oral, Personal and Home Care			873				874				1,751				1,741
Pet Nutrition			191				167				393				331
Corporate(1)			(118	)			(153	)			(246	)			(305	)
Total Operating Profit		$	946			$	888			$	1,898			$	1,767

Note:
(1) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs and gains and losses on sales of non-core product lines and assets.

Corporate Operating profit (loss) for the three months ended June 30, 2019 included charges of $40 resulting from the Global Growth and Efficiency Program, which ended on December 31, 2019.

Corporate Operating profit (loss) for the six months ended June 30, 2020 included a charge for acquisition-related costs of $6. Corporate Operating profit (loss) for the six months ended June 30, 2019 included charges of $68 resulting from the Global Growth and Efficiency Program, which ended on December 31, 2019.

Table 6
Colgate-Palmolive Company
Geographic Sales Analysis Percentage Changes
For the Three Months Ended June 30, 2020 vs. 2019
(Unaudited)
								COMPONENTS OF SALES CHANGE
														Pricing
														Coupons
		Sales												Consumer &
		Change			Organic			As Reported			Organic			Trade			Foreign
Region		As Reported			Sales Change			Volume			Volume			Incentives			Exchange
Total Company(1)		1.0	%		5.5	%		3.5	%		2.0	%		3.5	%		(6.0	)%
North America(1)		12.0	%		11.0	%		13.0	%		11.5	%		(0.5	)%		(0.5	)%
Latin America		(13.5	)%		4.5	%		(4.5	)%		(4.5	)%		9.0	%		(18.0	)%
Europe(1)		5.0	%		(1.5	)%		7.5	%		(1.5	)%		—	%		(2.5	)%
Asia Pacific		(3.0	)%		0.5	%		(3.0	)%		(3.0	)%		3.5	%		(3.5	)%
Africa/Eurasia(1)		(6.0	)%		2.5	%		0.5	%		(1.5	)%		4.0	%		(10.5	)%
Total CP Products(1)		(1.0	)%		4.0	%		2.5	%		0.5	%		3.5	%		(7.0	)%
Hill’s		9.5	%		11.5	%		7.5	%		7.5	%		4.0	%		(2.0	)%
Emerging Markets(2)		(9.0	)%		2.5	%		(3.5	)%		(4.0	)%		6.5	%		(12.0	)%
Developed Markets(2)		10.0	%		8.0	%		10.0	%		7.0	%		1.0	%		(1.0	)%

Notes:
(1) The impact of the previously disclosed acquisitions of the Filorga skin health business, the new joint venture in Nigeria and the Hello oral care business on as reported volume was 1.5% for Total Company and 1.5%, 9.0%, 2.0% and 2.0% for North America, Europe, Africa/Eurasia and Total CP Products, respectively.

(2) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe. The impact of the previously disclosed acquisitions of the Filorga skin health business, the new joint venture in Nigeria and the Hello oral care business on as reported volume was 0.5% for Emerging Markets and 3.0% for Developed Markets.

Table 7
Colgate-Palmolive Company
Geographic Sales Analysis Percentage Changes
For the Six Months Ended June 30, 2020 and 2019
(Unaudited)
								COMPONENTS OF SALES CHANGE
														Pricing
														Coupons
		Sales												Consumer &
		Change			Organic			As Reported			Organic			Trade			Foreign
Region		As Reported			Sales Change			Volume			Volume			Incentives			Exchange
Total Company(1)		3.0	%		6.5	%		5.5	%		4.0	%		2.5	%		(5.0	)%
North America(1)		10.5	%		9.5	%		11.0	%		9.5	%		—	%		(0.5	)%
Latin America		(7.0	)%		7.5	%		(0.5	)%		(0.5	)%		8.0	%		(14.5	)%
Europe(1)		8.5	%		2.5	%		12.0	%		3.5	%		(1.0	)%		(2.5	)%
Asia Pacific		(6.5	)%		(3.5	)%		(6.0	)%		(6.0	)%		2.5	%		(3.0	)%
Africa/Eurasia(1)		(0.5	)%		5.0	%		5.5	%		3.5	%		1.5	%		(7.5	)%
Total CP Products(1)		1.0	%		4.5	%		4.0	%		2.0	%		2.5	%		(5.5	)%
Hill’s		14.5	%		16.0	%		12.0	%		12.0	%		4.0	%		(1.5	)%
Emerging Markets(2)		(6.0	)%		2.5	%		(2.0	)%		(2.5	)%		5.0	%		(9.0	)%
Developed Markets(2)		12.0	%		10.0	%		12.0	%		9.0	%		1.0	%		(1.0	)%

Notes:
(1) The impact of the previously disclosed acquisitions of the Filorga skin health business, the new joint venture in Nigeria and the Hello oral care business on as reported volume was 1.5% for Total Company and 1.5%, 8.5%, 2.0% and 2.0% for North America, Europe, Africa/Eurasia and Total CP Products, respectively.

(2) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe. The impact of the previously disclosed acquisitions of the Filorga skin health business, the new joint venture in Nigeria and the Hello oral care business on as reported volume was 0.5% for Emerging Markets and 3.0% for Developed Markets.

Table 8
Colgate-Palmolive Company
Non-GAAP Reconciliations
For the Three Months Ended June 30, 2020 and 2019
(Dollars in Millions Except Per Share Amounts) (Unaudited)
Gross Profit		2020				2019
Gross profit, GAAP		$	2,369			$	2,308
Global Growth and Efficiency Program			—				(3	)
Gross profit, non-GAAP		$	2,369			$	2,305
										Basis Point
Gross Profit Margin		2020				2019				Change
Gross profit margin, GAAP			60.8	%			59.7	%		110
Global Growth and Efficiency Program			—	%			(0.1	)%
Gross profit margin, non-GAAP			60.8	%			59.6	%		120
Selling, General and Administrative Expenses		2020				2019
Selling, general and administrative expenses, GAAP		$	1,395			$	1,369
Global Growth and Efficiency Program			—				(10	)
Selling, general and administrative expenses, non-GAAP		$	1,395			$	1,359
Selling, General and Administrative Expenses as a Percentage of Net Sales		2020				2019				Basis Point Change
Selling, general and administrative expenses as a percentage of Net sales, GAAP			35.8	%			35.4	%		40
Global Growth and Efficiency Program			—	%			(0.2	)%
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP			35.8	%			35.2	%		60
Other (Income) Expense, Net		2020				2019
Other (income) expense, net, GAAP		$	28			$	51
Global Growth and Efficiency Program			—				(33	)
Other (income) expense, net, non-GAAP		$	28			$	18
Operating Profit		2020				2019				% Change
Operating profit, GAAP		$	946			$	888			7	%
Global Growth and Efficiency Program			—				40
Operating profit, non-GAAP		$	946			$	928			2	%
										Basis Point
Operating Profit Margin		2020				2019				Change
Operating profit margin, GAAP			24.3	%			23.0	%		130
Global Growth and Efficiency Program			—	%			1.0	%
Operating profit margin, non-GAAP			24.3	%			24.0	%		30
Non-Service Related Postretirement Costs		2020				2019
Non-service related postretirement costs, GAAP		$	20			$	27
Global Growth and Efficiency Program			—				(2	)
Non-service related postretirement costs, non-GAAP		$	20			$	25

Table 8
Continued
Colgate-Palmolive Company
Non-GAAP Reconciliations
For the Three Months Ended June 30, 2020 and 2019
(Dollars in Millions Except Per Share Amounts) (Unaudited)
		2020
		Income Before Income Taxes			Provision For Income Taxes(1)			Net Income Including Noncontrolling Interests			Net Income Attributable To Colgate-Palmolive Company			Effective Income Tax Rate(2)			Diluted Earnings Per Share
As Reported GAAP		$	891		$	216		$	675		$	635		24.2	%		$	0.74
Non-GAAP		$	891		$	216		$	675		$	635		24.2	%		$	0.74
		2019
		Income Before Income Taxes			Provision For Income Taxes(1)			Net Income Including Noncontrolling Interests			Net Income Attributable To Colgate-Palmolive Company			Effective Income Tax Rate(2)			Diluted Earnings Per Share
As Reported GAAP		$	823		$	205		$	618		$	586		24.9	%		$	0.68
Global Growth and Efficiency Program			42			11			31			31		0.1	%			0.04
Non-GAAP		$	865		$	216		$	649		$	617		25.0	%		$	0.72

The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

Notes:
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.

Table 9
Colgate-Palmolive Company
Non-GAAP Reconciliations
For the Six Months Ended June 30, 2020 and 2019
(Dollars in Millions Except Per Share Amounts) (Unaudited)
Gross Profit		2020				2019
Gross profit, GAAP		$	4,834			$	4,595
Acquisition-related costs			4				—
Global Growth and Efficiency Program			—				8
Gross profit, non-GAAP		$	4,838			$	4,603
										Basis Point
Gross Profit Margin		2020				2019				Change
Gross profit margin, GAAP			60.5	%			59.3	%		120
Global Growth and Efficiency Program			—	%			0.1	%
Gross profit margin, non-GAAP			60.5	%			59.4	%		110
Selling, General and Administrative Expenses		2020				2019
Selling, general and administrative expenses, GAAP		$	2,868			$	2,734
Global Growth and Efficiency Program			—				(14	)
Selling, general and administrative expenses, non-GAAP		$	2,868			$	2,720
Selling, General and Administrative Expenses as a Percentage of Net Sales		2020				2019				Basis Point Change
Selling, general and administrative expenses as a percentage of Net sales, GAAP			35.9	%			35.3	%		60
Global Growth and Efficiency Program			—	%			(0.2	)%
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP			35.9	%			35.1	%		80
Other (Income) Expense, Net		2020				2019
Other (income) expense, net, GAAP		$	68			$	94
Acquisition-related costs			(2	)			—
Global Growth and Efficiency Program			—				(46	)
Other (income) expense, net, non-GAAP		$	66			$	48
Operating Profit		2020				2019				% Change
Operating profit, GAAP		$	1,898			$	1,767			7	%
Acquisition-related costs			6				—
Global Growth and Efficiency Program			—				68
Operating profit, non-GAAP		$	1,904			$	1,835			4	%
										Basis Point
Operating Profit Margin		2020				2019				Change
Operating profit margin, GAAP			23.7	%			22.8	%		90
Global Growth and Efficiency Program			—	%			0.9	%
Operating profit margin, non-GAAP			23.8	%			23.7	%		10
Non-Service Related Postretirement Costs		2020				2019
Non-service related postretirement costs, GAAP		$	41			$	52
Global Growth and Efficiency Program			—				(3	)
Non-service related postretirement costs, non-GAAP		$	41			$	49

Table 9
Continued
Colgate-Palmolive Company
Non-GAAP Reconciliations
For the Six Months Ended June 30, 2020 and 2019
(Dollars in Millions Except Per Share Amounts) (Unaudited)
		2020
		Income Before Income Taxes			Provision For Income Taxes(1)			Net Income Including Noncontrolling Interests				Net Income Attributable To Colgate-Palmolive Company				Effective Income Tax Rate(2)			Diluted Earnings Per Share
As Reported GAAP		$	1,786		$	363		$	1,423			$	1,350			20.3	%		$	1.57
Subsidiary and operating structure initiatives			—			71			(71	)			(71	)		4	%			(0.08	)
Acquisition-related costs			6			2			4				4			—	%			—
Non-GAAP		$	1,792		$	436		$	1,356			$	1,283			24.3	%		$	1.49
		2019
		Income Before Income Taxes			Provision For Income Taxes(1)			Net Income Including Noncontrolling Interests				Net Income Attributable To Colgate-Palmolive Company				Effective Income Tax Rate(2)			Diluted Earnings Per Share
As Reported GAAP		$	1,637		$	419		$	1,218			$	1,146			25.6	%		$	1.33
Global Growth and Efficiency Program			71			18			53				53			—	%			0.06
Non-GAAP		$	1,708		$	437		$	1,271			$	1,199			25.6	%		$	1.39

The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

Notes:
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.